Cargando…
Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning
Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusivel...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751651/ https://www.ncbi.nlm.nih.gov/pubmed/23938043 http://dx.doi.org/10.1186/1477-7819-11-184 |
_version_ | 1782281642051633152 |
---|---|
author | Kumagai, Koji Okamura, Terue Toyoda, Masao Senzaki, Hideto Watanabe, Chihiro Ohmichi, Masahide |
author_facet | Kumagai, Koji Okamura, Terue Toyoda, Masao Senzaki, Hideto Watanabe, Chihiro Ohmichi, Masahide |
author_sort | Kumagai, Koji |
collection | PubMed |
description | Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusively using (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT), and treated by low anterior resection with total mesorectal excision aiming for macroscopic complete resection. The treatment goals for the patient were gradually changed from curative to palliative chemotherapy; she survived for 45 months without rectal obstruction after secondary debulking surgery, and was followed up until autopsy. Thus, (18)F-FDG PET/CT may be valuable for detecting rectal lymph node metastasis and can play an essential role in planning treatment for recurrent ovarian carcinoma. |
format | Online Article Text |
id | pubmed-3751651 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37516512013-08-24 Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning Kumagai, Koji Okamura, Terue Toyoda, Masao Senzaki, Hideto Watanabe, Chihiro Ohmichi, Masahide World J Surg Oncol Case Report Although uncommon, ovarian cancer cells may spread to the rectal lymph nodes. However, few reports have described how to detect and treat such metastases. We report a case of a 59-year-old woman with mesorectal and pararectal lymph node metastases in recurrent ovarian carcinoma, detected conclusively using (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT), and treated by low anterior resection with total mesorectal excision aiming for macroscopic complete resection. The treatment goals for the patient were gradually changed from curative to palliative chemotherapy; she survived for 45 months without rectal obstruction after secondary debulking surgery, and was followed up until autopsy. Thus, (18)F-FDG PET/CT may be valuable for detecting rectal lymph node metastasis and can play an essential role in planning treatment for recurrent ovarian carcinoma. BioMed Central 2013-08-12 /pmc/articles/PMC3751651/ /pubmed/23938043 http://dx.doi.org/10.1186/1477-7819-11-184 Text en Copyright ©2013 Kumagai et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Kumagai, Koji Okamura, Terue Toyoda, Masao Senzaki, Hideto Watanabe, Chihiro Ohmichi, Masahide Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning |
title | Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning |
title_full | Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning |
title_fullStr | Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning |
title_full_unstemmed | Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning |
title_short | Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)F-FDG PET/CT in treatment planning |
title_sort | rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of (18)f-fdg pet/ct in treatment planning |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751651/ https://www.ncbi.nlm.nih.gov/pubmed/23938043 http://dx.doi.org/10.1186/1477-7819-11-184 |
work_keys_str_mv | AT kumagaikoji rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning AT okamuraterue rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning AT toyodamasao rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning AT senzakihideto rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning AT watanabechihiro rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning AT ohmichimasahide rectallymphnodemetastasisinrecurrentovariancarcinomaessentialroleof18ffdgpetctintreatmentplanning |